Lorviqua – Lorlatinib uses, dose and side effects
Lorviqua contains the active substance lorlatinib, a medicine used to treat advanced stage adults of a type of lung cancer called non- small cell lung cancer (NSCLC). Lorviqua belongs to a group of medicines that inhibit an enzyme called anaplastic lymphoma kinase (ALK). Lorviqua is only given to patients who have a change in the ALK gene, see
Read More